Insulin Resistance is Associated with Significant Liver Fibrosis in Chronic Hepatitis C Patients

A Systemic Review and Meta-Analysis

Suhag Patel, Raxitkumar Jinjuvadia, Ravi Patel, Suthat Liangpunsakul

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The role of insulin resistance (IR) on fibrosis progression in hepatitis C virus (HCV) patients has not been systematically evaluated. Therefore, this systemic review aimed to summarize the available epidemiologic evidence to evaluate the strength of association between IR and advanced liver fibrosis in these patients. Methods: We performed a systemic literature search in PubMed, OvidSP, and MEDLINE from January 1990 to April 2015 without language restriction using the following search terms: insulin resistance, liver fibrosis, cirrhosis, diabetes mellitus, and chronic hepatitis C. Publication bias was assessed using the Begg and Egger tests and with a visual inspection of funnel plot. All analyses were performed using Comprehensive Meta-Analysis, version 2 software. Results: A total of 3659 participants with HCV infection from 14 studies were included in the analysis. After adjusting for publication bias, the relative risk (RR) for significant hepatic fibrosis among HCV subjects with IR was 1.63 [95% confidence interval (CI), 1.34-2.01]. Subgroup analysis by genotypes showed RR of 2.16 (95% CI, 1.52-3.06) for genotype 1; however, the association was no longer significant when we analyzed the data for HCV genotype 3; RR = 1.40 (95% CI, 0.8-2.45). Conclusion: Our study showed significant association between IR and significant hepatic fibrosis in patients with HCV genotype 1 infection.

Original languageEnglish (US)
Pages (from-to)80-84
Number of pages5
JournalJournal of Clinical Gastroenterology
Volume50
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Chronic Hepatitis C
Hepacivirus
Liver Cirrhosis
Insulin Resistance
Meta-Analysis
Genotype
Publication Bias
Fibrosis
Confidence Intervals
Liver
Virus Diseases
PubMed
MEDLINE
Diabetes Mellitus
Language
Software
Infection

Keywords

  • chronic hepatitis C
  • Insulin resistance
  • liver fibrosis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Insulin Resistance is Associated with Significant Liver Fibrosis in Chronic Hepatitis C Patients : A Systemic Review and Meta-Analysis. / Patel, Suhag; Jinjuvadia, Raxitkumar; Patel, Ravi; Liangpunsakul, Suthat.

In: Journal of Clinical Gastroenterology, Vol. 50, No. 1, 01.01.2016, p. 80-84.

Research output: Contribution to journalArticle

@article{fb6164df5d954cb88c855200d32ec42f,
title = "Insulin Resistance is Associated with Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis",
abstract = "The role of insulin resistance (IR) on fibrosis progression in hepatitis C virus (HCV) patients has not been systematically evaluated. Therefore, this systemic review aimed to summarize the available epidemiologic evidence to evaluate the strength of association between IR and advanced liver fibrosis in these patients. Methods: We performed a systemic literature search in PubMed, OvidSP, and MEDLINE from January 1990 to April 2015 without language restriction using the following search terms: insulin resistance, liver fibrosis, cirrhosis, diabetes mellitus, and chronic hepatitis C. Publication bias was assessed using the Begg and Egger tests and with a visual inspection of funnel plot. All analyses were performed using Comprehensive Meta-Analysis, version 2 software. Results: A total of 3659 participants with HCV infection from 14 studies were included in the analysis. After adjusting for publication bias, the relative risk (RR) for significant hepatic fibrosis among HCV subjects with IR was 1.63 [95{\%} confidence interval (CI), 1.34-2.01]. Subgroup analysis by genotypes showed RR of 2.16 (95{\%} CI, 1.52-3.06) for genotype 1; however, the association was no longer significant when we analyzed the data for HCV genotype 3; RR = 1.40 (95{\%} CI, 0.8-2.45). Conclusion: Our study showed significant association between IR and significant hepatic fibrosis in patients with HCV genotype 1 infection.",
keywords = "chronic hepatitis C, Insulin resistance, liver fibrosis",
author = "Suhag Patel and Raxitkumar Jinjuvadia and Ravi Patel and Suthat Liangpunsakul",
year = "2016",
month = "1",
day = "1",
doi = "10.1097/MCG.0000000000000400",
language = "English (US)",
volume = "50",
pages = "80--84",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Insulin Resistance is Associated with Significant Liver Fibrosis in Chronic Hepatitis C Patients

T2 - A Systemic Review and Meta-Analysis

AU - Patel, Suhag

AU - Jinjuvadia, Raxitkumar

AU - Patel, Ravi

AU - Liangpunsakul, Suthat

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The role of insulin resistance (IR) on fibrosis progression in hepatitis C virus (HCV) patients has not been systematically evaluated. Therefore, this systemic review aimed to summarize the available epidemiologic evidence to evaluate the strength of association between IR and advanced liver fibrosis in these patients. Methods: We performed a systemic literature search in PubMed, OvidSP, and MEDLINE from January 1990 to April 2015 without language restriction using the following search terms: insulin resistance, liver fibrosis, cirrhosis, diabetes mellitus, and chronic hepatitis C. Publication bias was assessed using the Begg and Egger tests and with a visual inspection of funnel plot. All analyses were performed using Comprehensive Meta-Analysis, version 2 software. Results: A total of 3659 participants with HCV infection from 14 studies were included in the analysis. After adjusting for publication bias, the relative risk (RR) for significant hepatic fibrosis among HCV subjects with IR was 1.63 [95% confidence interval (CI), 1.34-2.01]. Subgroup analysis by genotypes showed RR of 2.16 (95% CI, 1.52-3.06) for genotype 1; however, the association was no longer significant when we analyzed the data for HCV genotype 3; RR = 1.40 (95% CI, 0.8-2.45). Conclusion: Our study showed significant association between IR and significant hepatic fibrosis in patients with HCV genotype 1 infection.

AB - The role of insulin resistance (IR) on fibrosis progression in hepatitis C virus (HCV) patients has not been systematically evaluated. Therefore, this systemic review aimed to summarize the available epidemiologic evidence to evaluate the strength of association between IR and advanced liver fibrosis in these patients. Methods: We performed a systemic literature search in PubMed, OvidSP, and MEDLINE from January 1990 to April 2015 without language restriction using the following search terms: insulin resistance, liver fibrosis, cirrhosis, diabetes mellitus, and chronic hepatitis C. Publication bias was assessed using the Begg and Egger tests and with a visual inspection of funnel plot. All analyses were performed using Comprehensive Meta-Analysis, version 2 software. Results: A total of 3659 participants with HCV infection from 14 studies were included in the analysis. After adjusting for publication bias, the relative risk (RR) for significant hepatic fibrosis among HCV subjects with IR was 1.63 [95% confidence interval (CI), 1.34-2.01]. Subgroup analysis by genotypes showed RR of 2.16 (95% CI, 1.52-3.06) for genotype 1; however, the association was no longer significant when we analyzed the data for HCV genotype 3; RR = 1.40 (95% CI, 0.8-2.45). Conclusion: Our study showed significant association between IR and significant hepatic fibrosis in patients with HCV genotype 1 infection.

KW - chronic hepatitis C

KW - Insulin resistance

KW - liver fibrosis

UR - http://www.scopus.com/inward/record.url?scp=84951792894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951792894&partnerID=8YFLogxK

U2 - 10.1097/MCG.0000000000000400

DO - 10.1097/MCG.0000000000000400

M3 - Article

VL - 50

SP - 80

EP - 84

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 1

ER -